Home » Listing Details

ZOMIG® (zolmitriptan)
Official Web Site for ZOMIG® (zolmitriptan) prescription medication.

Listing Category: Health/Medicine/
URL: http://www.zomig.com/migraine-symptoms.aspx

Related news

Impax Pharmaceuticals Licenses Exclusive U.S. Commercialization Rights to Zomig® (zolmitriptan) from AstraZeneca
Impax Pharmaceuticals, the branded products business unit of Impax Laboratories, Inc. , announced today that it has licensed from AstraZeneca the exclusive United States commercial rights to Zomig® tablet, orally disintegrating tablet, and nasal spray formulations.
Press Release
Impax Laboratories Inc. Posted on:01 Feb 12 Impax Pharmaceuticals, the branded products business unit of Impax Laboratories, Inc. (NASDAQ: IPXL), announced today that it has licensed from AstraZeneca the exclusive United States (U.S.) commercial rights to Zomig® (zolmitriptan) tablet, orally disintegrating tablet, and nasal spray formulations.
AstraZeneca, Impax enter license agreement to commercialize Zomig in the U.S.
Impax Pharmaceuticals, the branded products business unit of Impax Laboratories, Inc., announced today that it has licensed from AstraZeneca the exclusive United States (U.S.) commercial rights to Zomig (zolmitriptan) tablet, orally disintegrating tablet, and nasal spray formulations.
Impax licenses exclusive commercialization rights to Zomig from AstraZeneca
Impax Pharmaceuticals announced today that it has licensed from AstraZeneca the exclusive United States commercial rights to Zomig tablet, orally disintegrating tablet, and nasal spray formulations. As ...
Impax acquires US rights to migraine drug Zomig
Impax Laboratories Inc. has acquired the U.S. rights to AstraZeneca PLC's migraine headache drug Zomig. The deal sent Impax's shares soaring Wednesday.Impax said it will pay AstraZeneca $130 million to ...
Impax Pharma Licenses US Commercial Rights For Zomig Tablet From AstraZeneca
Impax Pharma Licenses US Commercial Rights For Zomig Tablet From AstraZeneca